Personal Cellular Storage for Regenerative Medicine

Main Menu

Skip to content

Home

Trends in clinical use of point-of-care cell processing devices

November 26, 2013 · by Aviatior · in Biotechnology industry, Personalized Therapies, Regenerative Medicine. ·

http://stemcellassays.com/2013/10/trends-clinical-point-of-care-cell-processing-devices/

Related articles

A proposal for an allogeneic IPS cell bank – with a twist (transbiotex.wordpress.com)
Human neural stem cells could meet the clinical problem of critical limb ischemia (eurekalert.org)
Discovery Could Accelerate Body’s Response To Infection, Autoimmune Disorders, UT Southwestern Medical Center Study (biospace.com)
Large-scale cell production of stem cells for clinical application using the automated cell processing machine (biomedcentral.com)

Share this:

Share on Tumblr
Tweet
WhatsApp
Telegram
Email
Print
More

Pocket

Like this:

Like Loading...

Related

Tags: Adult stem cell, Adult Stem Cells, aging, Biology, Biomedical engineering, Biotechnology, Business, California Institute for Regenerative Medicine, Cancer, Cancer stem cell, Cell, Cell (biology), cell bank, Cell culture, cell differentiation, Cell potency, Cell type, clinical problem, Clinical trial, Conditions and Diseases, critical limb ischemia, Differentiation, DNA, DNA repair, Doctor of Philosophy, Embryonic stem cell, FDA, Food and Drug Administration, Fountain of Youth, Health, healthy aging, Hematopoietic stem cell, Hematopoietic stem cell transplantation, human stem cell, Induced pluripotent stem cell, iPS cell, iPS cell bank, Life extension, Medicine, Mesenchymal stem cell, Microarrays, nature, nerve cell, neural stem cell, neural stem cells, Neuron, Nobel Prize, Personalized medicine, Pluripotent Stem Cell, processing, Regenerative Medicine, Research and development, Research Groups and Centers, Science and Technology, Stem cell, stem cell research, Stem Cell Transplant, Stem Cell Treatment, Stem cells, Stem-cell therapy, Telomerase, Tissue (biology), Tissue engineering, TransBio-Tex, transbiotex, transplantation, Tumor, United States, UT Southwestern Medical Center Study

Post navigation

← The history of reprogramming 3.0

Congressman Touts Stem-Cell Lab Tour Despite Opposing Stem-Cell Research →

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (Address never made public)

Name

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

Notify me of new comments via email.

Notify me of new posts via email.

Δ

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Search

Archives

Archives

Blog Stats

144,282 hits

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 321 other followers

Email Address:

TransBio-Tex

$RSS Feed$ RSS - Posts

Follow on WordPress.com

Top clicks on this site

ipscell.com/2019/07/what-…

Translate this

Badge

Follow me on Facebook

Follow me on Facebook

Blog at WordPress.com.

Follow Following
- trans-bio-tex.com
- Already have a WordPress.com account? Log in now.

Loading Comments...

Write a Comment...

Email

Name

Website

Send to Email Address Your Name Your Email Address

Cancel

Post was not sent - check your email addresses!

Email check failed, please try again

Sorry, your blog cannot share posts by email.

%d bloggers like this: